文献速递心脑血管急症重症综合管理与镇静镇痛

多种神经预后评估算法的准确性及神经丝轻链检测对可除颤心律心脏骤停复苏后患者的附加价值:ISOCRATE 研究的辅助分析

The accuracy of various neuro-prognostication algorithms and the added value of neurofilament light chain dosage for patients resuscitated from shockable cardiac arrest: An ancillary analysis of the ISOCRATE study.
PubMed 文献 · Resuscitation · 2021-12-13
一句话结论可除颤心律心脏骤停复苏后 48 小时血 NF-L 高值与不良预后相关,按 500 pg/ml 阈值加入现行指南算法可提高敏感度且特异度仍高。

本研究为 ISOCRATE 随机试验的辅助分析,纳入可除颤心律心脏骤停复苏后患者,比较预后良好(CPC 1–2)与预后不良(CPC 3–5 或死亡)者复苏后 48 小时血清神经丝轻链(NF-L)水平,并评估将 NF-L 按 500 与 1,200 pg/ml 阈值加入现行指南算法后的预测价值。共 49 例患者检测 NF-L,预后良好者 48 小时中位 NF-L 为 72 ± 78 pg/ml,预后不良者为 7,755 ± 9,501 pg/ml(P < 0.0001;AUC 0.87[95%CI 0.74;0.99])。加入 NF-L 后,500 pg/ml 与 1,200 pg/ml 阈值的改良 ESICM/ERC 2021 算法敏感度分别为 0.74(95%CI 0.51–0.88)与 0.68(95%CI 0.46–0.86),未改良算法为 0.53(95%CI 0.32–0.73);三处特异度为 1。

要点

  • 可除颤心律心脏骤停复苏后 48 小时 NF-L:预后良好(CPC 1–2)中位 72 ± 78 pg/ml vs 预后不良(CPC 3–5 或死亡)7,755 ± 9,501 pg/ml,P < 0.0001,AUC 0.87(95%CI 0.74;0.99)。
  • 将 NF-L 按 500 pg/ml 阈值加入 ESICM/ERC 2021 算法,敏感度 0.74(95%CI 0.51–0.88),高于未改良算法的 0.53(95%CI 0.32–0.73)。
  • 将 NF-L 按 1,200 pg/ml 阈值加入同一算法,敏感度 0.68(95%CI 0.46–0.86),亦高于未改良算法的 0.53(95%CI 0.32–0.73)。
  • 改良算法在三个情形下特异度为 1。
  • 作者结论:复苏后 48 小时高血浆 NF-L 与不良预后显著相关;500 pg/ml 阈值加入现行指南算法敏感度最佳,同时特异度仍保持优异。

适用人群与场景

  • 参与随机 ISOCRATE 试验、可除颤心律并接受心肺复苏的患者,共 49 例检测 NF-L。
  • 预后按复苏后神经功能评估分为良好(CPC 1 或 2)与不良(CPC 3 至 5 或死亡)。

诊断标准与关键阈值

  • 神经功能预后分级采用大脑功能分类(CPC):良好为 CPC 1 或 2,不良为 CPC 3 至 5 或死亡。
  • NF-L 检测时间点为复苏自主循环恢复(ROSC)后 48 小时。
  • 评估的 NF-L 阈值包括 500 pg/ml 与 1,200 pg/ml,按既往描述的方式加入现行指南算法。

研究设计与关键结果

  • 研究类型为随机 ISOCRATE 试验的辅助分析,共 49 例患者检测 NF-L。
  • 预后良好者 ROSC 后 48 小时中位 NF-L 为 72 ± 78 pg/ml,预后不良者为 7,755 ± 9,501 pg/ml(P < 0.0001;AUC 0.87[95%CI 0.74;0.99])。
  • 加入 NF-L 500 pg/ml 阈值的改良 ESICM/ERC 2021 算法敏感度为 0.74(95%CI 0.51–0.88),1,200 pg/ml 阈值为 0.68(95%CI 0.46–0.86),未改良算法为 0.53(95%CI 0.32–0.73)。
  • 改良算法在三处情形下特异度为 1。

证据类型、等级与局限

  • 证据类型:随机对照试验 ISOCRATE 的辅助分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,复苏后 48 小时高血浆 NF-L 与不良预后显著相关。
  • 作者认为,将 NF-L 按 500 pg/ml 阈值在心脏骤停后 48 小时加入现行指南算法,与单用算法相比敏感度最佳,同时特异度仍保持优异。

指南或共识出处

  • 现行指南算法:ESICM/ERC 2021 算法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: In current guidelines, neurological prognostication after cardiopulmonary resuscitation is based on a multimodal approach bundled in algorithms. Biomarkers are of particular interest because they are unaffected by interpretation bias. We assessed the predictive value of serum neurofilament light chains (NF-L) in patients with a shockable rhythm who received cardiopulmonary resuscitation, and evaluated the predictive value of a modified algorithm where NF-L dosage is included.

METHODS: All patients who were included participated in the randomized ISOCRATE trial. NF-L values 48 h after ROSC were compared for patients with a good (Cerebral Performance Category (CPC) 1 or 2) and a poor prognosis (CPC 3 to 5 or death). The benefit of adding NF-L dosage to the current guideline algorithm was then assessed for NF-L thresholds of 500 and 1,200 pg/ml as previously described.

RESULTS: NF-L was assayed for 49 patients. In patients with good versus those with poor outcomes, median NF-L values at 48 h were 72 ± 78 and 7,755 ± 9,501 pg/ml respectively (P < 0.0001; AUC [95 %CI] = 0.87 [0.74;0.99]). The sensitivity of the modified ESICM/ERC 2021 algorithm after adding NF-L with thresholds of 500 and 1,200 pg/ml was 0.74 (CI 95% 0.51-0.88) and 0.68 (CI 95% 0.46-0.86), respectively, versus 0.53 (CI 95% 0.32-0.73) for the unmodified algorithm. In three instances the specificity was 1.

CONCLUSION: High NF-L plasma levels 48 h after cardiac arrest was significantly associated with a poor outcome. Adjunction to the current guideline algorithm of an NF-L assay with a 500 pg/ml threshold 48 h after cardiac arrest provided the best sensitivity compared to the algorithm alone, while specificity remained excellent.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Pouplet C, Colin G, Guichard E, et al. The accuracy of various neuro-prognostication algorithms and the added value of neurofilament light chain dosage for patients resuscitated from shockable cardiac arrest: An ancillary analysis of the ISOCRATE study. Resuscitation. 2021. PMID: 34915084. doi:10.1016/j.resuscitation.2021.12.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。